Gainers
- Ocuphire Pharma, Inc. (NASDAQ: OCUP) shares rose 27.8% to $2.67 in pre-market trading. Ocuphire Pharma entered into a global license agreement for development and commercialization of Nyxol Eye Drops for reversal of mydriasis, presbyopia and night vision disturbances.
- NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 25.5% to $2.71 in pre-market trading after dipping 17% on Monday. NeuroBo Pharmaceuticals recently announced pricing of a $30 million underwritten public offering and concurrent private placement.
- Hims & Hers Health, Inc. (NYSE: HIMS) rose 22.1% to $5.64 in pre-market trading after the company reported better-than-expected Q3 results. The company also issued Q4 and FY22 sales guidance above analyst estimates.
- Tenaya Therapeutics, Inc. (NASDAQ: TNYA) shares rose 17.7% to $2.26 in pre-market trading. Canaccord Genuity initiated coverage on Tenaya Therapeutics with a Buy rating and announced a price target of $21.
- uCloudlink Group Inc. (NASDAQ: UCL) rose 17.2% to $1.08 in pre-market trading after gaining over 4% on Monday.
- ContraFect Corporation (NASDAQ: CFRX) rose 15.2% to $0.1797 in pre-market trading after dropping over 5% on Monday.
- Lordstown Motors Corp. (NASDAQ: RIDE) rose 13.5% to $2.10 in pre-market trading after the company announced Foxconn will invest up to $170 million in the company.
- 2U, Inc. (NASDAQ: TWOU) rose 11.6% to $7.10 in pre-market trading after reporting strong Q3 sales. Piper Sandler upgraded 2U from Underweight to Neutral and lowered the price target from $8 to $7.
- TaskUs, Inc. (NASDAQ: TASK) rose 11% to $17.80 in pre-market trading after the company reported better-than-expected Q3 results. The company also issued Q4 and FY22 sales guidance above analyst estimates.
- LivePerson, Inc. (NASDAQ: LPSN) rose 10.7% to $11.21 in pre-market trading after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY22 sales guidance above analyst estimates.
- Lizhi Inc. (NASDAQ: LIZI) shares rose 9.9% to $0.51 in pre-market trading. LIZHI is expected to report Q3 financial results on Wednesday, November 16, 2022.
- SolarEdge Technologies, Inc. (NASDAQ: SEDG) rose 9.5% to $231.50 in pre-market trading after the company reported better-than-expected Q3 sales results and issued Q4 sales guidance with a midpoint above analyst estimates..
- CTI BioPharma Corp. (NASDAQ: CTIC) rose 8.8% to $5.41 in pre-market trading after the company reported better-than-expected Q3 EPS and sales results.
- Cango Inc. (NYSE: CANG) rose 7.2% to $2.69 in pre-market trading. Cango, last month, declared a special cash dividend of $0.50 per share.
- Ocugen, Inc. (NASDAQ: OCGN) rose 5.2% to $1.61 in pre-market trading.
Losers
- Athersys, Inc. (NASDAQ: ATHX) shares fell 43.4% to $1.28 in pre-market trading after the company reported a proposed public offering.
- Tripadvisor, Inc. (NASDAQ: TRIP) shares fell 19.5% to $19.16 in pre-market trading after the company reported worse-than-expected Q3 EPS results.
- Lyft (NASDAQ:LYFT), Inc. (NASDAQ: LYFT) shares fell 18.7% to $11.48 in pre-market trading after the company reported worse-than-expected Q3 sales results and issued Q4 sales guidance below analyst estimates. Evercore ISI Group downgraded Lyft from Outperform to In-Line and lowered the price target from $41 to $18.
- Take-Two (NASDAQ:TTWO) Interactive Software, Inc. (NASDAQ: TTWO) fell 18.7% to $88.16 in pre-market trading after the company reported worse-than-expected Q2 results and issued weak FY23 guidance.
- Nexalin Technology, Inc. (NASDAQ: NXL) fell 17.9% to $1.35 in pre-market trading.
- GreenPower Motor Company Inc. (NASDAQ: GP) fell 16.1% to $2.04 in pre-market trading after dropping 4% on Monday.
- Five9, Inc. (NASDAQ: FIVN) shares fell 12.7% to $41.00 in pre-market trading after the company issued EPS and sales guidance below analyst estimates.
- MicroCloud Hologram Inc. (NASDAQ: HOLO) shares fell 10.3% to $2.10 in pre-market trading after dropping over 7% on Monday.
- Agile Therapeutics, Inc. (NASDAQ: AGRX) fell 9.1% to $0.2899 in pre-market trading after the company reported a loss for its third quarter.
- NeuroMetrix, Inc. (NASDAQ: NURO) fell 8.3% to $1.64 in pre-market trading. NeuroMetrix recently announced the strategic launch of Quell Fibromyalgia.
- Broadmark Realty Capital Inc. (NYSE: BRMK) fell 8% to $5.18 in pre-market trading after reporting downbeat quarterly results. The company also named Jeffrey Pyatt as Interim CEO and Jonathan Hermes as Chief Financial Officer.
- Crown ElectroKinetics Corp. (NASDAQ: CRKN) fell 8% to $0.23 in pre-market trading. Crown Electrokinetics is expected to announce Q3 results on November 11, 2022.
- Ramaco Resources, Inc. (NASDAQ: METC) shares fell 7.2% to $11.58 in pre-market trading after the company reported worse-than-expected Q3 results.
- DigitalOcean Holdings, Inc. (NASDAQ: DOCN) fell 6.5% to $27.50 in pre-market trading after the company issued a weak forecast for the fourth quarter.